Britton Chance Laboratory of Redox Imaging

Focus

Britton Chance Laboratory of Redox Imaging brings together physicists, chemists, biologists, clinicians, and statisticians for cross-disciplinary biomedical imaging studies of the redox status coupled to reduced nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD) in conditions such as cancer, aging, and neurodegenerative diseases. We are currently developing optical/NMR imaging and spectroscopic biomarkers for cancer diagnosis, prognosis, and therapeutic response, and understanding the fundamental role of NAD- and FAD-coupled redox state in cancer transformation and progression to metastasis.

Leadership

Headshot of Lin Z. Li PhDLin Z. Li, PhD Director 
Headshot of He Nucleus Xu PhdHe N. Xu, PhD Associate Director 

Laboratory details